Cancer Clinical Trial -Zai Biopharmaceutical -ZL-1211-002=1

Cancer

Status:

Open

ClinicalTrials.gov:

NCT05065710

A Study of ZL-1211 in Patients With Advanced Solid Tumor

Drug

ZL-1211

Phase

Phase I

Condition

Advanced Solid Tumors

Keywords

 Clotting Protein 18-22

Reach out about this clinical trial

Researcher

Sunil Sharma